The Tumour Metabolism Inhibitors GSAO and PENAO React with Cysteines 57 and 257 of Mitochondrial Adenine Nucleotide Translocase

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2012 Mar 28

PMID 22448968

Citations 20

Authors

Danielle Park

Joyce Chiu

Gabriel G Perrone

Pierre J Dilda

Philip J Hogg

Affiliations

Soon will be listed here.

Abstract

Background: GSAO (4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid) and PENAO (4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid) are tumour metabolism inhibitors that target adenine nucleotide translocase (ANT) of the inner-mitochondrial membrane. Both compounds are currently being trialled in patients with solid tumours. The trivalent arsenical moiety of GSAO and PENAO reacts with two matrix facing cysteine residues of ANT, inactivating the transporter. This leads to proliferation arrest and death of tumour and tumour-supporting cells.

Results: The two reactive ANT cysteine residues have been identified in this study by expressing cysteine mutants of human ANT1 in Saccharomyces cerevisiae and measuring interaction with the arsenical moiety of GSAO and PENAO. The arsenic atom of both compounds cross-links cysteine residues 57 and 257 of human ANT1.

Conclusions: The sulphur atoms of these two cysteines are 20 Å apart in the crystal structures of ANT and the optimal spacing of cysteine thiolates for reaction with As (III) is 3-4 Å. This implies that a significant conformational change in ANT is required for the organoarsenicals to react with cysteines 57 and 257. This conformational change may relate to the selectivity of the compounds for proliferating cells.

Citing Articles

The Role and Applied Value of Mitochondria in Glioma-Related Research.

Chen L, Zhang H, Shang C, Hong Y CNS Neurosci Ther. 2024; 30(12):e70121.

PMID: 39639571 PMC: 11621238. DOI: 10.1111/cns.70121.

Modulatory Effect of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) on the 2-Oxoglutarate Mitochondrial Carrier.

Spagnoletta A, Miniero D, Gambacorta N, Oppedisano F, De Grassi A, Nicolotti O Molecules. 2024; 29(21).

PMID: 39519794 PMC: 11547764. DOI: 10.3390/molecules29215154.

New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction.

Miniero D, Gambacorta N, Spagnoletta A, Tragni V, Loizzo S, Nicolotti O J Clin Med. 2022; 11(24).

PMID: 36556135 PMC: 9785169. DOI: 10.3390/jcm11247519.

Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.

Seneviratne J, Carter D, Mittra R, Gifford A, Kim P, Luo J Int J Cancer. 2022; 152(7):1399-1413.

PMID: 36346110 PMC: 10953412. DOI: 10.1002/ijc.34349.

Citrate Regulates the Mitochondrial GDP/GTP Carrier (Ggc1p) by Triggering Unidirectional Transport of GTP.

Seccia R, De Santis S, Di Noia M, Palmieri F, Miniero D, Marmo R J Fungi (Basel). 2022; 8(8).

PMID: 36012783 PMC: 9410265. DOI: 10.3390/jof8080795.

References

Polcicova K, Kempna P, Sabova L, Gavurnikova G, Polcic P, Kolarov J . The delivery of ADP/ATP carrier protein to mitochondria probed by fusions with green fluorescent protein and beta-galactosidase. FEMS Yeast Res. 2003; 4(3):315-21. DOI: 10.1016/S1567-1356(03)00170-3. View

Ramsay E, Hogg P, Dilda P . Mitochondrial metabolism inhibitors for cancer therapy. Pharm Res. 2011; 28(11):2731-44. DOI: 10.1007/s11095-011-0584-5. View

Bauer M, Schubert A, Rocks O, Grimm S . Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol. 1999; 147(7):1493-502. PMC: 2174250. DOI: 10.1083/jcb.147.7.1493. View

Pedersen P, Mathupala S, Rempel A, Geschwind J, Ko Y . Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta. 2002; 1555(1-3):14-20. DOI: 10.1016/s0005-2728(02)00248-7. View

Ronicke V, GRAULICH W, Mumberg D, Muller R, Funk M . Use of conditional promoters for expression of heterologous proteins in Saccharomyces cerevisiae. Methods Enzymol. 1997; 283:313-22. DOI: 10.1016/s0076-6879(97)83025-x. View

Mathupala S, Rempel A, Pedersen P . Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem. 2001; 276(46):43407-12. DOI: 10.1074/jbc.M108181200. View

Halestrap A . What is the mitochondrial permeability transition pore?. J Mol Cell Cardiol. 2009; 46(6):821-31. DOI: 10.1016/j.yjmcc.2009.02.021. View

de Marcos Lousa C, Trezeguet V, Dianoux A, Brandolin G, Lauquin G . The human mitochondrial ADP/ATP carriers: kinetic properties and biogenesis of wild-type and mutant proteins in the yeast S. cerevisiae. Biochemistry. 2002; 41(48):14412-20. DOI: 10.1021/bi0261490. View

Kissova I, Polcic P, Kempna P, ZEMAN I, Sabova L, Kolarov J . The cytotoxic action of Bax on yeast cells does not require mitochondrial ADP/ATP carrier but may be related to its import to the mitochondria. FEBS Lett. 2000; 471(1):113-8. DOI: 10.1016/s0014-5793(00)01379-x. View

10.

McStay G, Clarke S, Halestrap A . Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J. 2002; 367(Pt 2):541-8. PMC: 1222909. DOI: 10.1042/BJ20011672. View

11.

Hatanaka T, Takemoto Y, Hashimoto M, MAJIMA E, Shinohara Y, Terada H . Significant expression of functional human type 1 mitochondrial ADP/ATP carrier in yeast mitochondria. Biol Pharm Bull. 2001; 24(6):595-9. DOI: 10.1248/bpb.24.595. View

12.

Rempel A, Bannasch P, Mayer D . Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim Biophys Acta. 1994; 1219(3):660-8. DOI: 10.1016/0167-4781(94)90225-9. View

13.

Zamora M, Merono C, Vinas O, Mampel T . Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem. 2004; 279(37):38415-23. DOI: 10.1074/jbc.M404928200. View

14.

ADAMS B . Induction of galactokinase in Saccharomyces cerevisiae: kinetics of induction and glucose effects. J Bacteriol. 1972; 111(2):308-15. PMC: 251283. DOI: 10.1128/jb.111.2.308-315.1972. View

15.

Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, Trezeguet V, Lauquin G, Brandolin G . Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature. 2003; 426(6962):39-44. DOI: 10.1038/nature02056. View

16.

Murgia M, Giorgi C, Pinton P, Rizzuto R . Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol. 2009; 46(6):781-8. PMC: 2851099. DOI: 10.1016/j.yjmcc.2009.03.003. View

17.

Daum G, Bohni P, Schatz G . Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are located in the intermembrane space of yeast mitochondria. J Biol Chem. 1982; 257(21):13028-33. View

18.

Goel A, Mathupala S, Pedersen P . Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression. J Biol Chem. 2003; 278(17):15333-40. DOI: 10.1074/jbc.M300608200. View

19.

Halestrap A, McStay G, Clarke S . The permeability transition pore complex: another view. Biochimie. 2002; 84(2-3):153-66. DOI: 10.1016/s0300-9084(02)01375-5. View

20.

Nury H, Dahout-Gonzalez C, Trezeguet V, Lauquin G, Brandolin G, Pebay-Peyroula E . Structural basis for lipid-mediated interactions between mitochondrial ADP/ATP carrier monomers. FEBS Lett. 2005; 579(27):6031-6. DOI: 10.1016/j.febslet.2005.09.061. View